An In Vitro Susceptibility Study of Cefotaxime-Sulbactam on Clinical Bacterial Isolates From Various Regions in India: A Comparison With Ceftriaxone-Sulbactam

Background and objective Combining sulbactam with cefotaxime/ceftriaxone augments its antimicrobial activity against β-lactamase-producing bacteria. They are widely used as empirical treatment for many clinical infections. However, there is a scarcity of data on the susceptibility of various organis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondane, Ajitkumar A, Pawar, Dattatray B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094748/
https://www.ncbi.nlm.nih.gov/pubmed/37056536
http://dx.doi.org/10.7759/cureus.36078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094748/
https://www.ncbi.nlm.nih.gov/pubmed/37056536
http://dx.doi.org/10.7759/cureus.36078

Ejemplares similares